Cancer is the leading cause of death in dogs over the age of 10 — affecting approximately 50% of dogs who reach that age. While supplements cannot treat or cure cancer, certain compounds play evidence-supported roles in immune function, reducing cancer cachexia, and supporting quality of life during and after conventional treatment.

What supplements can and cannot do in canine cancer

It's important to start with an honest baseline: no supplement replaces surgery, chemotherapy, or radiation for confirmed cancer. The role of supplements in canine oncology is supportive — reducing inflammatory burden, maintaining lean body mass, supporting immune function, and potentially reducing the side effects of treatment. Several compounds have peer-reviewed evidence in this role.

Omega-3 (EPA+DHA): the most evidence-supported supplement for cancer-affected dogs

Omega-3 fatty acids have the strongest evidence base for supporting cancer-affected dogs:

• Cancer cachexia: Cancer cells preferentially metabolize carbohydrates, while dogs and their healthy cells metabolize fat efficiently. High-dose omega-3 with reduced dietary carbohydrate reduces cancer cachexia — the muscle-wasting syndrome that significantly reduces quality of life and survival time in cancer-affected dogs.
• Anti-tumor immune function: EPA and DHA reduce pro-inflammatory cytokine production (IL-6, TNF-α, PGE2) while supporting NK cell and cytotoxic T-cell activity. This inflammatory reduction modulates the tumor microenvironment.
• Documented in veterinary oncology: The Tumor Necrosis Factor research from NC State University established omega-3 supplementation as a standard recommendation in companion animal oncology for dogs with lymphoma.

Dose for cancer-affected dogs: 40mg EPA+DHA per pound of body weight daily — approximately double the standard maintenance dose. A 60-lb dog needs approximately 2,400mg EPA+DHA daily.

Probiotics: gut-immune calibration during treatment

Chemotherapy and radiation significantly disrupt the gut microbiome. Antibiotic courses used during cancer treatment compound this dysbiosis. Probiotic supplementation during and after treatment reduces:

• Treatment-related diarrhea and gastrointestinal side effects
• Post-antibiotic gut microbiome disruption
• The systemic inflammatory load that impairs immune function

The gut-immune connection is particularly relevant in cancer — 70-80% of immune cells reside in gut-associated lymphoid tissue. Microbiome quality affects the effectiveness of cancer immunosurveillance.

Antioxidants: a nuanced picture

The role of antioxidants (vitamin C, vitamin E, quercetin) in dogs undergoing chemotherapy or radiation requires veterinary guidance. During active chemotherapy: some oncologists recommend avoiding high-dose antioxidants during treatment, as certain chemotherapy drugs work by generating reactive oxygen species (oxidative stress) that kill cancer cells — antioxidants may theoretically interfere with this mechanism. Post-treatment or for prevention: antioxidants support immune health and reduce long-term oxidative damage.

This nuance means quercetin and similar antioxidants should be discussed with your veterinary oncologist when a dog is undergoing active treatment.

Breeds with the highest cancer rates

Bernese Mountain Dogs, Golden Retrievers, Boxers, Rottweilers, and Scottish Terriers have the highest lifetime cancer rates. For these breeds, proactive omega-3 supplementation from 12–18 months of age is widely recommended by veterinary oncologists as part of a general wellness protocol — not as a cancer treatment, but as ongoing immune support and anti-inflammatory maintenance.

Related: omega-3 guide · probiotics guide · senior dog guide · Bernese Mountain Dog guide · Golden Retriever guide.